Subscribe To Our Free Newsletter |
Cipla ready to launch low-dose Efavirenz 400 mg
The pharma company is ready to supply its combinations Tenofovir/ Emtricitabine / Efavirenz and Tenofovir/ Lamivudine /Efavirenz with a dose of 400 mg of Efavirenz as a first-line initial therapy for HIV infection.